News

The U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for investigational bamlanivimab (LY-CoV555) 700 mg and etesevimab (LY-CoV016) 1400 mg together,…
Read More...

Hangzhou Chance Pharmaceuticals a clinical-stage biotechnology company focusing on discovering, developing and commercializing transformative inhalation therapies for the world’s most…
Read More...

Antibe Therapeutics Inc. announced that it has licensed otenaproxesul to Nuance Pharma for commercialization in the Greater China region. Nuance is a biopharmaceutical company focused…
Read More...

RotaChrom Technologies, the developer of the world's first industrial-scale Centrifugal Partition Chromatography (CPC) technology platform, announced the launch of a collaboration with…
Read More...

Freeline Therapeutics Holdings plc a clinical-stage biotechnology company developing transformative adeno-associated virus vector-mediated gene therapies for patients suffering from…
Read More...

Hoth Therapeutics, Inc. a biopharmaceutical company, today announced that it has signed an agreement with Camargo Pharmaceutical Services to facilitate the writing and submission of the…
Read More...

AC Immune SA a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, announced that the first patient has been scanned in a…
Read More...

Nautilus Biotechnology, Inc. a company pioneering a single-molecule protein analysis platform for quantifying the human proteome, and Arya Sciences Acquisition Corp III, a special…
Read More...

Veru Inc. an oncology biopharmaceutical company, today announced positive efficacy and safety results from a double-blind, randomized, placebo-controlled Phase 2 clinical trial…
Read More...

Novavax, Inc. a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the start of the rolling review process for authorization of…
Read More...

Merck and BioNTech are further expanding their strategic partnership. Merck, in close collaboration with BioNTech, will significantly accelerate the supply of urgently needed lipids and…
Read More...

Moderna, Inc. biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced that the Singapore Health Sciences Authority (HSA) has approved the interim…
Read More...

AstraZeneca’s Forxiga (dapagliflozin) has been approved in China to reduce the risk of cardiovascular (CV) death and hospitalisation for heart failure (hHF) in adults with heart failure…
Read More...

A pioneer in the development of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS) systems Swift Biosciences announces the addition of Bruce Zhang, Director of…
Read More...

Johnson & Johnson announced that Janssen Biotech, Inc., has submitted an application to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for…
Read More...

TCG Lifesciences Pvt. Ltd., a company controlled by New York-based The Chatterjee Group ("TCG"), has announced the expansion of its operations in the USA with the establishment of TCG…
Read More...

Tiziana Life Sciences plc a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, announces the completion of its clinical study…
Read More...

GlaxoSmithKline plc and CureVac N.V. announced a new €150m collaboration, building on their existing relationship, to jointly develop next generation mRNA vaccines for COVID-19 with the…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines,  announced the Swiss Federal Government has increased its confirmed order commitment…
Read More...

Matrix Medical Network announced a collaboration with global biopharmaceutical company AstraZeneca to accelerate a clinical trial in the US for AZD7442, AstraZeneca's long-acting…
Read More...